About INVIVOTEK LLC
Genesis Drug Discovery & Development (GD3) is a fully integrated CRO specializing in translational studies and preclinical in vivo pharmacology services, including disease modeling and drug discovery programs from target discovery through IND filing and Phase I-III clinical trials.
Disease modeling servicesPreclinical in vivo pharmacology servicesCustom and standard preclinical model development and validationPK/PD servicesToxicology and tolerability studiesDose range finding, MTD, and MABEL determinationIn vitro and in vivo ADME assaysBioanalysis and biomarker investigations
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| THREE PHASES OF MEDICATION TESTING | Department of Veterans Affairs | $99K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INVIVOTEK LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.